Kerrigan, Dennis J. PhD; Reddy, Madhulata MD; Walker, Eleanor M. MD; Cook, Bernard PhD; McCord, James MD; Loutfi, Randa MD; Saval, Matthew A. MS; Baxter, Jodi BS; Brawner, Clinton A. PhD; Keteyian, Steven J. PhD
Division of Cardiovascular Medicine (Drs Kerrigan, Reddy, McCord, Brawner, and Keteyian, Mr Saval, and Ms Baxter) and Department of Pathology (Dr Cook), Henry Ford Hospital, Detroit, Michigan; and Departments of Radiation Oncology (Dr Walker) and Medical Oncology (Dr Loutfi), Henry Ford Cancer Institute at Henry Ford Health System, Detroit, Michigan.
Correspondence: Dennis J. Kerrigan, PhD, Division of Cardiovascular Medicine, Henry Ford Hospital, 6525 Second Ave, Detroit, MI 48187 ([email protected]).
This study was supported by the Helen L. Key Charitable Trust and the Henry Ford Health System Game on Cancer Fund.
Dr James McCord has received consultant payments from Beckman, Roche, and Siemens, and has research grants as well with those three companies along with Abbott. None of the other authors have conflicts of interest to disclose. All authors have read and approved the article.